PXSLY : Summary for PHARMAXIS LTD ADR - Yahoo Finance

U.S. Markets closed

Pharmaxis Ltd (PXSLY)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
3.000.00 (0.00%)
At close: 10:30AM EDT
People also watch
QRXPYPOLXFCPIXSKYEYPGLA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.00
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume40
Market Cap68.66M
Beta-1.50
PE Ratio (TTM)-5.13
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire19 days ago

    Synairgen plc: Additional Positive Data in Lung Fibrosis

    SOUTHAMPTON, England, March 10, 2017 /PRNewswire/ -- - Phase I c linical trial s cheduled to start in H2 2017   Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, today announces ...

  • Pharmaxis Ltd. :PXSLY-US: Earnings Analysis: Q1, 2017 By the Numbers : October 31, 2016
    Capital Cube5 months ago

    Pharmaxis Ltd. :PXSLY-US: Earnings Analysis: Q1, 2017 By the Numbers : October 31, 2016

    Categories: Yahoo Finance Get free summary analysis Pharmaxis Ltd. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Pharmaxis Ltd. – Innoviva, Inc. (INVA-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 3.39 million, Net Earnings of USD -3.10 million. Earnings growth ... Read more (Read more...)

  • Pharmaxis Ltd. :PXSLY-US: Earnings Analysis: Q4, 2016 By the Numbers : August 22, 2016
    Capital Cube7 months ago

    Pharmaxis Ltd. :PXSLY-US: Earnings Analysis: Q4, 2016 By the Numbers : August 22, 2016

    Categories: Yahoo Finance Get free summary analysis Pharmaxis Ltd. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Pharmaxis Ltd. – Windtree Therapeutics, Inc., Innoviva, Inc., Acura Pharmaceuticals, Inc., Aradigm Corporation, Quintiles Transnational Holdings, Inc. and Rigel Pharmaceuticals, Inc. (WINT-US, INVA-US, ACUR-US, ARDM-US, Q-US and RIGL-US) that ... Read more (Read more...)